Healthware Group launches medical communications and education division
Modern medical communications for the contemporary clinician PRESS RELEASE | London, UK and Salerno, Italy | 27 July 2022 – Healthware Group …
People
VITA Accelerator: an opportunity for digital health startups
Over recent years, the world of health has been affected by the noteworthy digital transformation with a significant impact on the entire health syste…
CDP Venture Capital: Over 6 Million’s Worth Of Investments For VITA, The Start-Up Accelerator In Digital Health
CDP Venture Capital Sgr announces the birth of VITA, the accelerator for start-ups developing new solutions or services for the Health secto…
Healthware Group announces acquisition of Argon Global Healthcare Network
Global health innovation and technology leader, Healthware, has announced the acquisition of Argon Global Healthcare, one of the largest international…
Venture Capital Trends in Digital Health
During the Frontiers Health Global conference 2021, we met with Min-Sung Sean Kim, Managing Partner at Digital Health Ventures and member of the Front…
Consumer health innovation – where passion and science meet
Thsi article has been originally published at pharmaphorum.com/sales-marketing/consumer-health-innovation-jnj/ Heather Barnes, external innovation …
Healthware Group appoints Jonah Comstock as Editor-in-Chief
Health tech and digital health journalist Jonah Comstock will oversee the editorial assets of the Group London/Salerno, January 11, 2022 - Healthw…
Elizabeth Holmes: between a drop and a hard place
Business ethics lessons in the Digital Health care start-up culture Once considered by Forbes “the world's youngest self-made woman billionaire”, E…
A new era for digital health and medicine: A conversation with Ahmed Albaiti
Article originally published on zs.com by Pete Masloski on July 14, 2021 Digital health is maturing and accelerating like never before, with a wide…
An Innovation Fund lead by Entrepreneurs: Debiopharm’s Tanja Dowe on How Investors Support Startups
Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. The Fund invests in …